Virus-like particle-based vaccines for animal viral infections

Jennings, 2008, The coming of age of virus-like particle vaccines, Biol Chem, 389, 521, 10.1515/BC.2008.064 Liu, 2012, Virus-like particles: potential veterinary vaccine immunogens, Res Vet Sci, 93, 553, 10.1016/j.rvsc.2011.10.018 Plummer, 2011, Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design, Wiley Interdiscip Rev Nanomed Nanobiotechnol, 3, 174, 10.1002/wnan.119 D’Aoust, 2010, The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza, Plant Biotechnol J, 8, 607, 10.1111/j.1467-7652.2009.00496.x Bachmann, 2010, Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns, Nat Rev Immunol, 10, 787, 10.1038/nri2868 Kang, 2009, Influenza vaccines based on virus-like particles, Virus Res, 143, 140, 10.1016/j.virusres.2009.04.005 Haynes, 2009, Influenza virus-like particle vaccines, Expert Rev Vaccines, 8, 435, 10.1586/erv.09.8 Roy, 2008, Virus-like particles as a vaccine delivery system: myths and facts, Hum Vaccin, 4, 5, 10.4161/hv.4.1.5559 Ludwig, 2007, Virus-like particles-universal molecular toolboxes, Curr Opin Biotechnol, 18, 537, 10.1016/j.copbio.2007.10.013 Grgacic, 2006, Virus-like particles: passport to immune recognition, Methods, 40, 60, 10.1016/j.ymeth.2006.07.018 Noad, 2003, Virus-like particles as immunogens, Trends Microbiol, 11, 438, 10.1016/S0966-842X(03)00208-7 Douglas, 2006, Viruses: making friends with old foes, Science, 312, 873, 10.1126/science.1123223 Garcea, 2004, Virus-like particles as vaccines and vessels for the delivery of small molecules, Curr Opin Biotechnol, 15, 513, 10.1016/j.copbio.2004.10.002 Johnson, 2000, Structures of virus and virus-like particles, Curr Opin Struct Biol, 10, 229, 10.1016/S0959-440X(00)00073-7 Bachmann, 1997, Neutralizing antiviral B cell responses, Annu Rev Immunol, 15, 235, 10.1146/annurev.immunol.15.1.235 Kouskoff, 2000, T cell-independent rescue of B lymphocytes from peripheral immune tolerance, Science, 287, 2501, 10.1126/science.287.5462.2501 Chackerian, 1999, Induction of autoantibodies to mouse CCR5 with recombinant papillomavirus particles, Proc Natl Acad Sci U S A, 96, 2373, 10.1073/pnas.96.5.2373 Bachmann, 1993, The influence of antigen organization on B cell responsiveness, Science, 262, 1448, 10.1126/science.8248784 Fehr, 1998, T cell-independent type I antibody response against B cell epitopes expressed repetitively on recombinant virus particles, Proc Natl Acad Sci U S A, 95, 9477, 10.1073/pnas.95.16.9477 Scheerlinck, 2006, Particulate delivery systems for animal vaccines, Methods, 40, 118, 10.1016/j.ymeth.2006.05.023 Fifis, 2004, Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors, J Immunol, 173, 3148, 10.4049/jimmunol.173.5.3148 Xiang, 2006, Pathogen recognition and development of particulate vaccines: does size matter?, Methods, 40, 1, 10.1016/j.ymeth.2006.05.016 Liu, 2000, Papillomavirus virus-like particles for the delivery of multiple cytotoxic T cell epitopes, Virology, 273, 374, 10.1006/viro.2000.0435 Yan, 2004, Despite differences between dendritic cells and Langerhans cells in the mechanism of papillomavirus-like particle antigen uptake, both cells cross-prime T cells, Virology, 324, 297, 10.1016/j.virol.2004.03.045 Goldmann, 1999, Molecular cloning and expression of major structural protein VP1 of the human polyomavirus JC virus: formation of virus-like particles useful for immunological and therapeutic studies, J Virol, 73, 4465, 10.1128/JVI.73.5.4465-4469.1999 Gedvilaite, 2006, Virus-like particles derived from major capsid protein VP1 of different polyomaviruses differ in their ability to induce maturation in human dendritic cells, Virology, 354, 252, 10.1016/j.virol.2006.07.007 Tissot, 2010, Versatile virus-like particle carrier for epitope based vaccines, PLoS One, 5, e9809, 10.1371/journal.pone.0009809 Murata, 2003, Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection, Proc Natl Acad Sci U S A, 100, 6753, 10.1073/pnas.1131929100 Paliard, 2000, Priming of strong, broad, and long-lived HIV type 1 p55gag-specific CD8+ cytotoxic T cells after administration of a virus-like particle vaccine in rhesus macaques, AIDS Res Hum Retroviruses, 16, 273, 10.1089/088922200309368 Schirmbeck, 1996, Virus-like particles induce MHC class I-restricted T-cell responses. Lessons learned from the hepatitis B small surface antigen, Intervirology, 39, 111, 10.1159/000150482 Spohn, 2008, Exploiting viral properties for the rational design of modern vaccines, Expert Rev Vaccines, 7, 43, 10.1586/14760584.7.1.43 Roldao, 2010, Virus-like particles in vaccine development, Expert Rev Vaccines, 9, 1149, 10.1586/erv.10.115 Vicente, 2011, Large-scale production and purification of VLP-based vaccines, J Invertebr Pathol, 107, S42, 10.1016/j.jip.2011.05.004 Roy, 2009, Virus-like particles as a vaccine delivery system: myths and facts, Adv Exp Med Biol, 655, 145, 10.1007/978-1-4419-1132-2_11 Chackerian, 2007, Virus-like particles: flexible platforms for vaccine development, Expert Rev Vaccines, 6, 381, 10.1586/14760584.6.3.381 Conner, 2004, Virus-like particle vaccines, 283 Casal, 2001, Use of the baculovirus expression system for the generation of virus-like particles, Biotechnol Genet Eng Rev, 18, 73, 10.1080/02648725.2001.10648009 Bragard, 2000, Virus-like particles assemble in plants and bacteria expressing the coat protein gene of Indian peanut clump virus, J Gen Virol, 81, 267, 10.1099/0022-1317-81-1-267 Jagadish, 1996, Chimeric potyvirus-like particles as vaccine carriers, Intervirology, 39, 85, 10.1159/000150479 Lacasse, 2008, Novel plant virus-based vaccine induces protective cytotoxic T-lymphocyte-mediated antiviral immunity through dendritic cell maturation, J Virol, 82, 785, 10.1128/JVI.01811-07 Wilschut, 2009, Influenza vaccines: the virosome concept, Immunol Lett, 122, 118, 10.1016/j.imlet.2008.11.006 Bachmann, 2004, Virus-like particles: combining innate and adaptive immunity for effective vaccination, 415 Jegerlehner, 2002, A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses, Vaccine, 20, 3104, 10.1016/S0264-410X(02)00266-9 Mateu, 2011, Virus engineering: functionalization and stabilization, Protein Eng Des Sel, 24, 53, 10.1093/protein/gzq069 Strable, 2009, Chemical modification of viruses and virus-like particles, Curr Top Microbiol Immunol, 327, 1, 10.1007/978-3-540-69379-6_1 Raja, 2003, Hybrid virus-polymer materials: 1. Synthesis and properties of PEG-decorated cowpea mosaic virus, Biomacromolecules, 4, 472, 10.1021/bm025740+ Storni, 2004, Nonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects, J Immunol, 172, 1777, 10.4049/jimmunol.172.3.1777 Zhao, 2011, Self-assembled virus-like particles from rotavirus structural protein VP6 for targeted drug delivery, Bioconjug Chem, 22, 346, 10.1021/bc1002532 Monie, 2008, Cervarix: a vaccine for the prevention of HPV 16, 18-associated cervical cancer, Biologics, 2, 97 Shi, 2007, GARDASIL: prophylactic human papillomavirus vaccine development – from bench top to bed-side, Clin Pharmacol Ther, 81, 259, 10.1038/sj.clpt.6100055 Roldao, 2011, Viruses and virus-like particles in biotechnology: fundamentals and applications, 625 Branco, 2010, Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever, Virol J, 7, 279, 10.1186/1743-422X-7-279 Li, 2010, Hantavirus-like particles generated in CHO cells induce specific immune responses in C57BL/6 mice, Vaccine, 28, 4294, 10.1016/j.vaccine.2010.04.025 Warfield, 2011, Advances in virus-like particle vaccines for filoviruses, J Infect Dis, 204, S1053, 10.1093/infdis/jir346 Garrone, 2011, A prime-boost strategy using virus-like particles pseudotyped for HCV proteins triggers broadly neutralizing antibodies in macaques, Sci Transl Med, 3, 94ra71, 10.1126/scitranslmed.3002330 Mena, 2011, Insect cell technology is a versatile and robust vaccine manufacturing platform, Expert Rev Vaccines, 10, 1063, 10.1586/erv.11.24 Segales, 2002, Postweaning multisystemic wasting syndrome (PMWS) in pigs. A review, Vet Q, 24, 109, 10.1080/01652176.2002.9695132 Martelli, 2011, One dose of a porcine circovirus 2 subunit vaccine induces humoral and cell-mediated immunity and protects against porcine circovirus-associated disease under field conditions, Vet Microbiol, 149, 339, 10.1016/j.vetmic.2010.12.008 Fort, 2008, Porcine circovirus type 2 (PCV2) vaccination of conventional pigs prevents viremia against PCV2 isolates of different genotypes and geographic origins, Vaccine, 26, 1063, 10.1016/j.vaccine.2007.12.019 Fort, 2009, One dose of a porcine circovirus 2 (PCV2) sub-unit vaccine administered to 3-week-old conventional piglets elicits cell-mediated immunity and significantly reduces PCV2 viremia in an experimental model, Vaccine, 27, 4031, 10.1016/j.vaccine.2009.04.028 Fachinger, 2008, The effect of vaccination against porcine circovirus type 2 in pigs suffering from porcine respiratory disease complex, Vaccine, 26, 1488, 10.1016/j.vaccine.2007.11.053 Antonis, 2006, A novel recombinant virus-like particle vaccine for prevention of porcine parvovirus-induced reproductive failure, Vaccine, 24, 5481, 10.1016/j.vaccine.2006.03.089 Ju, 2011, Goose parvovirus structural proteins expressed by recombinant baculoviruses self-assemble into virus-like particles with strong immunogenicity in goose, Biochem Biophys Res Commun, 409, 131, 10.1016/j.bbrc.2011.04.129 Le Gall-Recule, 1996, Expression of muscovy duck parvovirus capsid proteins (VP2 and VP3) in a baculovirus expression system and demonstration of immunity induced by the recombinant proteins, J Gen Virol, 77, 2159, 10.1099/0022-1317-77-9-2159 Christensen, 1994, Production of mink enteritis parvovirus empty capsids by expression in a baculovirus vector system: a recombinant vaccine for mink enteritis parvovirus in mink, J Gen Virol, 75, 149, 10.1099/0022-1317-75-1-149 Lopez de Turiso, 1992, Recombinant vaccine for canine parvovirus in dogs, J Virol, 66, 2748, 10.1128/JVI.66.5.2748-2753.1992 Saliki, 1992, Canine parvovirus empty capsids produced by expression in a baculovirus vector: use in analysis of viral properties and immunization of dogs, J Gen Virol, 73, 369, 10.1099/0022-1317-73-2-369 Brun, 2011, Current strategies for subunit and genetic viral veterinary vaccine development, Virus Res, 157, 1, 10.1016/j.virusres.2011.02.006 Kang, 2009, Influenza virus-like particles as pandemic vaccines, Curr Top Microbiol Immunol, 333, 269, 10.1007/978-3-540-92165-3_14 Lopez-Macias, 2011, Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico, Vaccine, 29, 7826, 10.1016/j.vaccine.2011.07.099 Morrison, 2010, Newcastle disease virus-like particles as a platform for the development of vaccines for human and agricultural pathogens, Future Virol, 5, 545, 10.2217/fvl.10.50 Pyo, 2012, Pandemic H1N1 influenza virus-like particles are immunogenic and provide protective immunity to pigs, Vaccine, 30, 1297, 10.1016/j.vaccine.2011.12.083 Flick, 2005, Rift valley fever virus, Curr Mol Med, 5, 827, 10.2174/156652405774962263 Naslund, 2009, Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus, Virology, 385, 409, 10.1016/j.virol.2008.12.012 Bishop, 1996, Natural history of human rotavirus infection, Arch Virol Suppl, 12, 119 Jiang, 1999, Heterotypic protection from rotavirus infection in mice vaccinated with virus-like particles, Vaccine, 17, 1005, 10.1016/S0264-410X(98)00317-X Conner, 1993, Rotavirus vaccine administered parenterally induces protective immunity, J Virol, 67, 6633, 10.1128/JVI.67.11.6633-6641.1993 Yuan, 2000, Intranasal administration of 2/6-rotavirus-like particles with mutant Escherichia coli heat-labile toxin (LT-R192G) induces antibody-secreting cell responses but not protective immunity in gnotobiotic pigs, J Virol, 74, 8843, 10.1128/JVI.74.19.8843-8853.2000 Fernandez, 1998, Passive immunity to bovine rotavirus in newborn calves fed colostrum supplements from cows immunized with recombinant SA11 rotavirus core-like particle (CLP) or virus-like particle (VLP) vaccines, Vaccine, 16, 507, 10.1016/S0264-410X(97)80004-7 Bertolotti-Ciarlet, 2003, Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice, Vaccine, 21, 3885, 10.1016/S0264-410X(03)00308-6 Maclachlan, 2009, The pathology and pathogenesis of bluetongue, J Comp Pathol, 141, 1, 10.1016/j.jcpa.2009.04.003 Niedbalski, 2011, Bluetongue vaccines in Europe, Pol J Vet Sci, 14, 299, 10.2478/v10181-011-0048-1 Roy, 1992, Protective efficacy of virus-like particles for bluetongue disease, Vaccine, 10, 28, 10.1016/0264-410X(92)90415-G Roy, 1990, Recombinant virus vaccine for bluetongue disease in sheep, J Virol, 64, 1998, 10.1128/JVI.64.5.1998-2003.1990 Stewart, 2012, Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection, Vaccine, 30, 2131, 10.1016/j.vaccine.2012.01.042 Nasir, 2008, Bovine papillomaviruses: their role in the aetiology of cutaneous tumours of bovids and equids, Vet Dermatol, 19, 243, 10.1111/j.1365-3164.2008.00683.x Hainisch, 2011, Safety and immunogenicity of BPV-1 L1 virus-like particles in a dose-escalation vaccination trial in horses, Equine Vet J, 44, 107, 10.1111/j.2042-3306.2011.00390.x Campo, 1997, Vaccination against papillomavirus in cattle, Clin Dermatol, 15, 275, 10.1016/S0738-081X(96)00165-4 Breitburd, 1995, Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection, J Virol, 69, 3959, 10.1128/JVI.69.6.3959-3963.1995 Suzich, 1995, Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas, Proc Natl Acad Sci U S A, 92, 11553, 10.1073/pnas.92.25.11553 Bank-Wolf, 2010, Zoonotic aspects of infections with noroviruses and sapoviruses, Vet Microbiol, 140, 204, 10.1016/j.vetmic.2009.08.021 Almanza, 2008, Self-assembly of the recombinant capsid protein of a swine norovirus into virus-like particles and evaluation of monoclonal antibodies cross-reactive with a human strain from genogroup II, J Clin Microbiol, 46, 3971, 10.1128/JCM.01204-08 Wang, 2005, Porcine noroviruses related to human noroviruses, Emerg Infect Dis, 11, 1874, 10.3201/eid1112.050485 Angulo, 2007, Towards a unique and transmissible vaccine against myxomatosis and rabbit haemorrhagic disease for rabbit populations, Wildl Res, 34, 567, 10.1071/WR06160 Cooke, 2002, Rabbit haemorrhagic disease: field epidemiology and the management of wild rabbit populations, Rev Sci Tech, 21, 347, 10.20506/rst.21.2.1337 Luque, 2012, Epitope insertion at the N-terminal molecular switch of the rabbit hemorrhagic disease virus t=3 capsid protein leads to larger t=4 capsids, J Virol, 86, 6470, 10.1128/JVI.07050-11 Coyne, 2006, Lethal outbreak of disease associated with feline calicivirus infection in cats, Vet Rec, 158, 544, 10.1136/vr.158.16.544 Tacket, 2003, Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers, Clin Immunol, 108, 241, 10.1016/S1521-6616(03)00120-7 Souza, 2007, A human norovirus-like particle vaccine adjuvanted with ISCOM or mLT induces cytokine and antibody responses and protection to the homologous GII.4 human norovirus in a gnotobiotic pig disease model, Vaccine, 25, 8448, 10.1016/j.vaccine.2007.09.040 Han, 2006, Immune responses to bovine norovirus-like particles with various adjuvants and analysis of protection in gnotobiotic calves, Vaccine, 24, 317, 10.1016/j.vaccine.2005.07.071 Laurent, 1994, Recombinant rabbit hemorrhagic disease virus capsid protein expressed in baculovirus self-assembles into viruslike particles and induces protection, J Virol, 68, 6794, 10.1128/JVI.68.10.6794-6798.1994 Perez-Filgueira, 2007, Development of a low-cost, insect larvae-derived recombinant subunit vaccine against RHDV, Virology, 364, 422, 10.1016/j.virol.2007.03.016 Plana-Duran, 1996, Oral immunization of rabbits with VP60 particles confers protection against rabbit hemorrhagic disease, Arch Virol, 141, 1423, 10.1007/BF01718245 Nagesha, 1995, Self-assembly, antigenicity, and immunogenicity of the rabbit haemorrhagic disease virus (Czechoslovakian strain V-351) capsid protein expressed in baculovirus, Arch Virol, 140, 1095, 10.1007/BF01315418 Di Martino, 2007, Assembly of feline calicivirus-like particle and its immunogenicity, Vet Microbiol, 120, 173, 10.1016/j.vetmic.2006.10.021 Li, 1997, Identification of noncytopathic equine rhinovirus 1 as a cause of acute febrile respiratory disease in horses, J Clin Microbiol, 35, 937, 10.1128/JCM.35.4.937-943.1997 Lynch, 2011, Equine rhinitis A virus-like particle expressing DNA vaccine induces a virus neutralising immune response in mice, Virus Res, 158, 294, 10.1016/j.virusres.2011.04.009 Cao, 2009, Synthesis of empty capsid-like particles of Asia I foot-and-mouth disease virus in insect cells and their immunogenicity in guinea pigs, Vet Microbiol, 137, 10, 10.1016/j.vetmic.2008.12.007 Abrams, 1995, Assembly of foot-and-mouth disease virus empty capsids synthesized by a vaccinia virus expression system, J Gen Virol, 76, 3089, 10.1099/0022-1317-76-12-3089 Lewis, 1991, Expression, processing, and assembly of foot-and-mouth disease virus capsid structures in heterologous systems: induction of a neutralizing antibody response in guinea pigs, J Virol, 65, 6572, 10.1128/JVI.65.12.6572-6580.1991 Gelmetti, 2006, Pathogenesis of encephalomyocarditis experimental infection in young piglets: a potential animal model to study viral myocarditis, Vet Res, 37, 15, 10.1051/vetres:2005041 Billinis, 1999, Persistence of encephalomyocarditis virus (EMCV) infection in piglets, Vet Microbiol, 70, 171, 10.1016/S0378-1135(99)00137-6 Jeoung, 2011, Immunogenicity and safety of virus-like particle of the porcine encephalomyocarditis virus in pig, Virol J, 8, 170, 10.1186/1743-422X-8-170 Pope, 1991, Chicken anemia agent, Vet Immunol Immunopathol, 30, 51, 10.1016/0165-2427(91)90008-Z Koch, 1995, Immunogenic and protective properties of chicken anaemia virus proteins expressed by baculovirus, Vaccine, 13, 763, 10.1016/0264-410X(94)00034-K Berg, 2000, Acute infectious bursal disease in poultry: a review, Avian Pathol, 29, 175, 10.1080/03079450050045431 Martinez-Torrecuadrada, 2003, Structure-dependent efficacy of infectious bursal disease virus (IBDV) recombinant vaccines, Vaccine, 21, 3342, 10.1016/S0264-410X(02)00804-6 McGinnes, 2010, Assembly and biological and immunological properties of Newcastle disease virus-like particles, J Virol, 84, 4513, 10.1128/JVI.01931-09 Azad, 2005, Nodavirus infection causes mortalities in hatchery produced larvae of Lates calcarifer: first report from India, Dis Aquat Organ, 63, 113, 10.3354/dao063113 Thiery, 2006, Induction of a protective immune response against viral nervous necrosis in the European sea bass Dicentrarchus labrax by using betanodavirus virus-like particles, J Virol, 80, 10201, 10.1128/JVI.01098-06 Liu, 2006, Immune response against grouper nervous necrosis virus by vaccination of virus-like particles, Vaccine, 24, 6282, 10.1016/j.vaccine.2006.05.073 Clarke, 1987, Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein, Nature, 330, 381, 10.1038/330381a0 Beesley, 1990, Expression in yeast of amino-terminal peptide fusions to hepatitis B core antigen and their immunological properties, Biotechnology (NY), 8, 644, 10.1038/nbt0790-644 Jin, 2007, Protective immune responses against foot-and-mouth disease virus by vaccination with a DNA vaccine expressing virus-like particles, Viral Immunol, 20, 429, 10.1089/vim.2007.0031 Ruedl, 2005, Virus-like particles as carriers for T-cell epitopes: limited inhibition of T-cell priming by carrier-specific antibodies, J Virol, 79, 717, 10.1128/JVI.79.2.717-724.2005 Albrecht, 1977, Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure, J Pediatr, 91, 715, 10.1016/S0022-3476(77)81021-4 Vitour, 2011, Colostral antibody induced interference of inactivated bluetongue serotype-8 vaccines in calves, Vet Res, 42, 18, 10.1186/1297-9716-42-18 Storni, 2002, Critical role for activation of antigen-presenting cells in priming of cytotoxic T cell responses after vaccination with virus-like particles, J Immunol, 168, 2880, 10.4049/jimmunol.168.6.2880 Wang, 2012, Virus-like particles of hepatitis B virus core protein containing five mimotopes of infectious bursal disease virus (IBDV) protect chickens against IBDV, Vaccine, 30, 2125, 10.1016/j.vaccine.2012.01.040 Pircher, 1990, Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo, Nature, 346, 629, 10.1038/346629a0 Mazeike, 2012, Induction of insert-specific immune response in mice by hamster polyomavirus VP1 derived virus-like particles carrying LCMV GP33 CTL epitope, Virus Res, 163, 2, 10.1016/j.virusres.2011.08.003 Eriksson, 2011, Murine polyomavirus virus-like particles carrying full-length human PSA protect BALB/c mice from outgrowth of a PSA expressing tumor, PLoS One, 6, e23828, 10.1371/journal.pone.0023828 Sedlik, 1997, Recombinant parvovirus-like particles as an antigen carrier: a novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells, Proc Natl Acad Sci U S A, 94, 7503, 10.1073/pnas.94.14.7503 Pan, 2008, Development of recombinant porcine parvovirus-like particles as an antigen carrier formed by the hybrid VP2 protein carrying immunoreactive epitope of porcine circovirus type 2, Vaccine, 26, 2119, 10.1016/j.vaccine.2008.02.037 Barcena, 2004, The coat protein of Rabbit hemorrhagic disease virus contains a molecular switch at the N-terminal region facing the inner surface of the capsid, Virology, 322, 118, 10.1016/j.virol.2004.01.021 Crisci, 2009, Chimeric calicivirus-like particles elicit protective anti-viral cytotoxic responses without adjuvant, Virology, 387, 303, 10.1016/j.virol.2009.02.045 Peacey, 2008, Virus-like particles from rabbit hemorrhagic disease virus can induce an anti-tumor response, Vaccine, 26, 5334, 10.1016/j.vaccine.2008.07.074 Crisci, 2012, Chimeric calicivirus-like particles elicit specific immune responses in pigs, Vaccine, 30, 2427, 10.1016/j.vaccine.2012.01.069 El Mehdaoui, 2000, Gene transfer using recombinant rabbit hemorrhagic disease virus capsids with genetically modified DNA encapsidation capacity by addition of packaging sequences from the L1 or L2 protein of human papillomavirus type 16, J Virol, 74, 10332, 10.1128/JVI.74.22.10332-10340.2000 Murawski, 2010, Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology, J Virol, 84, 1110, 10.1128/JVI.01709-09 Stephenne, 1988, Recombinant versus plasma-derived hepatitis B vaccines: issues of safety, immunogenicity and cost-effectiveness, Vaccine, 6, 299, 10.1016/0264-410X(88)90173-9 Buckland, 2005, The process development challenge for a new vaccine, Nat Med, 11, S16, 10.1038/nm1218 Cox, 2012, Recombinant protein vaccines produced in insect cells, Vaccine, 30, 1759, 10.1016/j.vaccine.2012.01.016 Vicente, 2011, Rational design and optimization of downstream processes of virus particles for biopharmaceutical applications: current advances, Biotechnol Adv, 29, 869, 10.1016/j.biotechadv.2011.07.004 Yusibov, 2006, The potential of plant virus vectors for vaccine production, Drugs R D, 7, 203, 10.2165/00126839-200607040-00001 Rybicki, 2009, Plant-produced vaccines: promise and reality, Drug Discov Today, 14, 16, 10.1016/j.drudis.2008.10.002 Middelberg, 2011, A microbial platform for rapid and low-cost virus-like particle and capsomere vaccines, Vaccine, 29, 7154, 10.1016/j.vaccine.2011.05.075 van Oers, 2011, Opportunities and challenges for the baculovirus expression system, J Invertebr Pathol, 107, S3, 10.1016/j.jip.2011.05.001 Hervas-Stubbs, 2007, Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN, J Immunol, 178, 2361, 10.4049/jimmunol.178.4.2361 Rueda, 2000, Effect of different baculovirus inactivation procedures on the integrity and immunogenicity of porcine parvovirus-like particles, Vaccine, 19, 726, 10.1016/S0264-410X(00)00259-0 Marek, 2011, Engineering of baculovirus vectors for the manufacture of virion-free biopharmaceuticals, Biotechnol Bioeng, 108, 1056, 10.1002/bit.23028 Meeusen, 2007, Current status of veterinary vaccines, Clin Microbiol Rev, 20, 489, 10.1128/CMR.00005-07 Kratz, 1999, Native display of complete foreign protein domains on the surface of hepatitis B virus capsids, Proc Natl Acad Sci U S A, 96, 1915, 10.1073/pnas.96.5.1915 Caballero, 2004, Structural requirements of astrovirus virus-like particles assembled in insect cells, J Virol, 78, 13285, 10.1128/JVI.78.23.13285-13292.2004 Charpilienne, 2001, Individual rotavirus-like particles containing 120 molecules of fluorescent protein are visible in living cells, J Biol Chem, 276, 29361, 10.1074/jbc.M101935200 Neirynck, 1999, A universal influenza A vaccine based on the extracellular domain of the M2 protein, Nat Med, 5, 1157, 10.1038/13484 Jeoung, 2010, Immune responses and expression of the virus-like particle antigen of the porcine encephalomyocarditis virus, Res Vet Sci, 89, 295, 10.1016/j.rvsc.2010.03.012 Istrate, 2008, Parenteral administration of RF 8-2/6/7 rotavirus-like particles in a one-dose regimen induce protective immunity in mice, Vaccine, 26, 4594, 10.1016/j.vaccine.2008.05.089 Conner, 1996, Virus-like particles as a rotavirus subunit vaccine, J Infect Dis, 174, S88, 10.1093/infdis/174.Supplement_1.S88 Peacey, 2007, Versatile RHDV virus-like particles: incorporation of antigens by genetic modification and chemical conjugation, Biotechnol Bioeng, 98, 968, 10.1002/bit.21518